Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11220%2F25%3A10497424" target="_blank" >RIV/00216208:11220/25:10497424 - isvavai.cz</a>
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=mDpyxbrfCL" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=mDpyxbrfCL</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1017/bca.2024.45" target="_blank" >10.1017/bca.2024.45</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic
Popis výsledku v původním jazyce
Cannabis is the most commonly used illicit drug worldwide. In countries with repressive drug policies, the costs of its prohibition plausibly outweigh the benefits. We conduct a cost-benefit analysis of cannabis legalization and regulation in the Czech Republic, taking into consideration alternative scenarios designed using parameters from the known effects of cannabis legalization in selected U.S. states, Canada, and Uruguay. Our analysis focuses on tax revenues, law enforcement costs, the cost of treatment and harm reduction, and the value of Quality Adjusted Life Years (QALYs). Under all the projected scenarios, the identified benefits of legalizing cannabis for personal use exceed the potential costs. The estimated net social benefit of legalization is in the range of 34.4 to 107.6 million EUR per year (or between 3.2 and 10.1 EUR per capita), depending on the size of the cannabis market and the development of cannabis prices after legalization.
Název v anglickém jazyce
Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic
Popis výsledku anglicky
Cannabis is the most commonly used illicit drug worldwide. In countries with repressive drug policies, the costs of its prohibition plausibly outweigh the benefits. We conduct a cost-benefit analysis of cannabis legalization and regulation in the Czech Republic, taking into consideration alternative scenarios designed using parameters from the known effects of cannabis legalization in selected U.S. states, Canada, and Uruguay. Our analysis focuses on tax revenues, law enforcement costs, the cost of treatment and harm reduction, and the value of Quality Adjusted Life Years (QALYs). Under all the projected scenarios, the identified benefits of legalizing cannabis for personal use exceed the potential costs. The estimated net social benefit of legalization is in the range of 34.4 to 107.6 million EUR per year (or between 3.2 and 10.1 EUR per capita), depending on the size of the cannabis market and the development of cannabis prices after legalization.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
50501 - Law
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Benefit-Cost Analysis
ISSN
2194-5888
e-ISSN
2152-2812
Svazek periodika
2025
Číslo periodika v rámci svazku
Neuveden
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
27
Strana od-do
1-27
Kód UT WoS článku
001454111300001
EID výsledku v databázi Scopus
2-s2.0-105001869700